Literature DB >> 16314836

Genome-wide DNA copy number alterations in head and neck squamous cell carcinomas with or without oncogene-expressing human papillomavirus.

S J Smeets1, B J M Braakhuis, S Abbas, P J F Snijders, B Ylstra, M A van de Wiel, G A Meijer, C R Leemans, R H Brakenhoff.   

Abstract

Oncogene-expressing human papillomavirus type 16 (HPV16) is found in a subset of head and neck squamous cell carcinomas (HNSCC). HPV16 drives carcinogenesis by inactivating p53 and pRb with the viral oncoproteins E6 and E7, paralleled by a low level of mutations in TP53 and allelic loss at 3p, 9p, and 17p, genetic changes frequently found in HNSCCs of nonviral etiology. We hypothesize that two pathways to HNSCC exist: one determined by HPV16 and the other by environmental carcinogens. To define the critical genetic events in these two pathways, we now present a detailed genome analysis of HNSCC with and without HPV16 involvement by employing high-resolution microarray comparative genomic hybridization. Four regions showed alterations in HPV-negative tumors that were absent in HPV-positive tumors: losses at 3p11.2-26.3, 5q11.2-35.2, and 9p21.1-24, and gains/amplifications at 11q12.1-13.4. Also, HPV16-negative tumors demonstrated loss at 18q12.1-23, in contrast to gain in HPV16-positive tumors. Seven regions were altered at high frequency (>33%) in both groups: gains at 3q22.2-qter, 5p15.2-pter, 8p11.2-qter, 9q22-34.1, and 20p-20q, and losses at 11q14.1-qter and 13q11-33. These data show that HNSCC arising by environmental carcinogens are characterized by genetic alterations that differ from those observed in HPV16-induced HNSCC, and most likely occur early in carcinogenesis. A number of genetic changes are shared in both tumor groups and can be considered crucial in the later stages of HNSCC progression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16314836     DOI: 10.1038/sj.onc.1209275

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  94 in total

1.  Human papillomavirus and survival of patients with oropharyngeal cancer.

Authors:  K Kian Ang; Jonathan Harris; Richard Wheeler; Randal Weber; David I Rosenthal; Phuc Felix Nguyen-Tân; William H Westra; Christine H Chung; Richard C Jordan; Charles Lu; Harold Kim; Rita Axelrod; C Craig Silverman; Kevin P Redmond; Maura L Gillison
Journal:  N Engl J Med       Date:  2010-06-07       Impact factor: 91.245

2.  Early esophageal squamous cell carcinoma in a western series is not associated with active HPV infection.

Authors:  Christina Kanaan; Diane Lorenzo; Maximilien Barret; Anne Audebourg; Sarah Leblanc; Stanislas Chaussade; Frédéric Prat; Benoît Terris
Journal:  Virchows Arch       Date:  2020-06-10       Impact factor: 4.064

3.  Battling cancer on many fronts. Meeting on New Battlefields in Human Cancer--Attacking in Many Fronts.

Authors:  Fabian Zanella; Amancio Carnero
Journal:  EMBO Rep       Date:  2008-09       Impact factor: 8.807

4.  MVisAGe Identifies Concordant and Discordant Genomic Alterations of Driver Genes in Squamous Tumors.

Authors:  Vonn Walter; Ying Du; Ludmila Danilova; Michele C Hayward; D Neil Hayes
Journal:  Cancer Res       Date:  2018-04-26       Impact factor: 12.701

Review 5.  Current potential and limitations of molecular diagnostic methods in head and neck cancer.

Authors:  Magdy E Mahfouz; Juan P Rodrigo; Robert P Takes; Mohamed N Elsheikh; Alessandra Rinaldo; Ruud H Brakenhoff; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-06       Impact factor: 2.503

6.  High HPV16 E6 viral load in the oral cavity is associated with an increased number of bacteria: A preliminary study.

Authors:  Hideo Shigeishi; Masaru Sugiyama; Kouji Ohta; Sho Yokoyama; Miyuki Sakuma; Hiroshi Murozumi; Hiroki Kato; Masaaki Takechi
Journal:  Biomed Rep       Date:  2017-11-29

7.  Integrative molecular characterization of head and neck cancer cell model genomes.

Authors:  Ivy F L Tsui; Cathie Garnis
Journal:  Head Neck       Date:  2010-09       Impact factor: 3.147

8.  Human papillomavirus infection as a prognostic factor in oropharyngeal squamous cell carcinomas treated in a prospective phase II clinical trial.

Authors:  Solomon Jo; Agnes Juhasz; Keqiang Zhang; Christopher Ruel; Sofia Loera; Sharon P Wilczynski; Yun Yen; Xiyong Liu; Joshua Ellenhorn; Dean Lim; Benjamin Paz; George Somlo; Nayana Vora; Stephen Shibata
Journal:  Anticancer Res       Date:  2009-05       Impact factor: 2.480

Review 9.  Therapeutic insights from genomic studies of head and neck squamous cell carcinomas.

Authors:  Peter S Hammerman; D Neil Hayes; Jennifer R Grandis
Journal:  Cancer Discov       Date:  2015-02-02       Impact factor: 39.397

10.  CGHregions: dimension reduction for array CGH data with minimal information loss.

Authors:  Mark A van de Wiel; Wessel N van Wieringen
Journal:  Cancer Inform       Date:  2007-02-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.